Your browser doesn't support javascript.
loading
Disruptions of Anaerobic Gut Bacteria Are Associated with Stroke and Post-stroke Infection: a Prospective Case-Control Study.
Haak, Bastiaan W; Westendorp, Willeke F; van Engelen, Tjitske S R; Brands, Xanthe; Brouwer, Matthijs C; Vermeij, Jan-Dirk; Hugenholtz, Floor; Verhoeven, Aswin; Derks, Rico J; Giera, Martin; Nederkoorn, Paul J; de Vos, Willem M; van de Beek, Diederik; Wiersinga, W Joost.
Afiliação
  • Haak BW; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Westendorp WF; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.
  • van Engelen TSR; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Brands X; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Brouwer MC; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.
  • Vermeij JD; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.
  • Hugenholtz F; Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Verhoeven A; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Derks RJ; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Giera M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Nederkoorn PJ; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.
  • de Vos WM; Laboratory of Microbiology, Wageningen University, Wageningen, The Netherlands.
  • van de Beek D; Human Microbiome Research Program, Faculty of Medicine, Helsinki University, Helsinski, Finland.
  • Wiersinga WJ; Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, location AMC,, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. d.vandebeek@amsterdamumc.nl.
Transl Stroke Res ; 12(4): 581-592, 2021 08.
Article em En | MEDLINE | ID: mdl-33052545
ABSTRACT
In recent years, preclinical studies have illustrated the potential role of intestinal bacterial composition in the risk of stroke and post-stroke infections. The results of these studies suggest that bacteria capable of producing volatile metabolites, including trimethylamine-N-oxide (TMAO) and butyrate, play opposing, yet important roles in the cascade of events leading to stroke. However, no large-scale studies have been undertaken to determine the abundance of these bacterial communities in stroke patients and to assess the impact of disrupted compositions of the intestinal microbiota on patient outcomes. In this prospective case-control study, rectal swabs from 349 ischemic and hemorrhagic stroke patients (median age, 71 years; IQR 67-75) were collected within 24 h of hospital admission. Samples were subjected to 16S rRNA amplicon sequencing and subsequently compared with samples obtained from 51 outpatient age- and sex-matched controls (median age, 72 years; IQR, 62-80) with similar cardiovascular risk profiles but without active signs of stroke. Plasma protein biomarkers were analyzed using a combination of nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-mass spectrometry (LC-MS). Alpha and beta diversity analyses revealed higher disruption of intestinal communities during ischemic and hemorrhagic stroke compared with non-stroke matched control subjects. Additionally, we observed an enrichment of bacteria implicated in TMAO production and a loss of butyrate-producing bacteria. Stroke patients displayed two-fold lower plasma levels of TMAO than controls (median 1.97 vs 4.03 µM, Wilcoxon p < 0.0001). Finally, lower abundance of butyrate-producing bacteria within 24 h of hospital admission was an independent predictor of enhanced risk of post-stroke infection (odds ratio 0.77, p = 0.005), but not of mortality or functional patient outcome. In conclusion, aberrations in trimethylamine- and butyrate-producing gut bacteria are associated with stroke and stroke-associated infections.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Transl Stroke Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Transl Stroke Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda